ADAR1 Capital Management, LLC
Holdings as of 2026-06-30, filed 2026-08-14
This is history, not a current position. These holdings describe 2026-06-30, and the report became public 45 days later. The portfolio has changed since.
Aggregates
computed from the positions belowPositions reported
277
Value reported by manager
$2.2B
Sum of our stored positions
$2.2B
should match the line above
Disclosure lag
45 d
quarter end to filing
Top 5 concentration
30.3%
of the positions shown
New positions
0
vs previous quarter
Exited
0
vs previous quarter
Option positions
8
puts and calls
Positions
200 largest shown| Issuer | Class | Value | Shares | Type | CUSIP |
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | $240.5M | 1,804,703 | — | 00370M103 |
| PROTAGONIST THERAPEUTICS INC | COM | $117.8M | 960,863 | — | 74366E102 |
| ROIVANT SCIENCES LTD | SHS | $111.7M | 3,157,008 | — | G76279101 |
| STATE STR SPDR S&P 500 ETF T | TR UNIT | $96.4M | 129,087 | — | 78462F103 |
| IMMUNOVANT INC | COM | $89.8M | 2,330,716 | — | 45258J102 |
| ZAI LAB LTD | ADR | $64M | 3,369,034 | — | 98887Q104 |
| AGIOS PHARMACEUTICALS INC | COM | $47.8M | 1,288,053 | — | 00847X104 |
| CRINETICS PHARMACEUTICALS IN | COM | $45.7M | 1,222,080 | — | 22663K107 |
| EA SERIES TRUST | ALPHA ARCH 1-3 | $39.5M | 337,125 | — | 02072L565 |
| CYTOKINETICS INC | COM NEW | $39M | 457,907 | — | 23282W605 |
| SEPTERNA INC | COM | $31.5M | 940,747 | — | 81734D104 |
| ANTERIS TECHNOLOGIES GLOBAL | COM | $31M | 3,145,096 | — | 03675P102 |
| EDITAS MEDICINE INC | COM | $28.8M | 8,889,000 | — | 28106W103 |
| DENALI THERAPEUTICS INC | COM | $26.5M | 1,029,080 | — | 24823R105 |
| SPYRE THERAPEUTICS INC | COM NEW | $25.2M | 283,982 | — | 00773J202 |
| VIR BIOTECHNOLOGY INC | COM | $25M | 2,456,677 | — | 92764N102 |
| PRAXIS PRECISION MEDICINES I | COM NEW | $24.9M | 74,253 | — | 74006W207 |
| INSMED INC | COM PAR $.01 | $24.4M | 228,520 | — | 457669307 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | $23.1M | 619,542 | — | 15117B202 |
| VIKING THERAPEUTICS INC | COM | $22.4M | 574,038 | — | 92686J106 |
| TAYSHA GENE THERAPIES INC | COM SHS | $20.7M | 3,040,466 | — | 877619106 |
| MONOPAR THERAPEUTICS INC | COM NEW | $20.1M | 217,595 | — | 61023L207 |
| OVID THERAPEUTICS INC | COM | $20M | 7,417,479 | — | 690469101 |
| ENLIVEN THERAPEUTICS INC | COM | $19.7M | 387,718 | — | 29337E102 |
| ENANTA PHARMACEUTICALS INC | COM | $19.6M | 1,344,510 | — | 29251M106 |
| ISHARES TR | RUSSELL 2000 ETF | $18.8M | 62,500 | Put | 464287655 |
| STATE STR SPDR S&P 500 ETF T | TR UNIT | $18.7M | 25,000 | Put | 78462F103 |
| NEKTAR THERAPEUTICS | COM NEW | $17M | 244,184 | — | 640268306 |
| INSPIRE MED SYS INC | COM | $16.7M | 374,617 | — | 457730109 |
| REVOLUTION MEDICINES INC | COM | $16.4M | 87,509 | — | 76155X100 |
| ESTABLISHMENT LABS HLDGS INC | COM | $15.9M | 185,619 | — | G31249108 |
| PROTHENA CORP PLC | SHS | $15.2M | 1,554,535 | — | G72800108 |
| RHYTHM PHARMACEUTICALS INC | COM | $15.1M | 136,158 | — | 76243J105 |
| INHIBIKASE THERAPEUTICS INC | COM NEW | $15M | 7,387,205 | — | 45719W205 |
| UNIQURE NV | SHS | $15M | 324,672 | — | N90064101 |
| RALLYBIO CORP | COM | $14.8M | 926,352 | — | 75120L209 |
| REGENERON PHARMACEUTICALS | COM | $13.8M | 22,208 | — | 75886F107 |
| INVENTIVA SA | ADS | $13.6M | 3,606,656 | — | 46124U107 |
| SUTRO BIOPHARMA INC | COM SHS | $13.4M | 404,014 | — | 869367201 |
| IONIS PHARMACEUTICALS INC | COM | $13.2M | 166,286 | — | 462222100 |
| BRIDGEBIO PHARMA INC | COM | $13.2M | 176,689 | — | 10806X102 |
| SAREPTA THERAPEUTICS INC | COM | $13.1M | 730,649 | — | 803607100 |
| CYTOMX THERAPEUTICS INC. | COM | $12.6M | 3,365,118 | — | 23284F105 |
| VOR BIOPHARMA INC | COM NEW | $12.5M | 680,626 | — | 929033207 |
| SPDR SERIES TRUST | ST STR BLO 1 ETF | $12.4M | 135,585 | — | 78468R663 |
| EQUILLIUM INC | COM | $12M | 3,758,569 | — | 29446K106 |
| ADLAI NORTYE LTD | SPONSORED ADS | $11.7M | 1,017,805 | — | 00704R109 |
| CLIMB BIO INC | COM | $10.7M | 822,649 | — | 28658R106 |
| SPDR SERIES TRUST | ST STR SP BIOT | $10.7M | 67,400 | Put | 78464A870 |
| HELIX ACQUISITION CORP III | USD CL A ORD SHS | $10.6M | 1,000,000 | — | G4444S107 |
| ZURA BIO LTD | CLASS A ORD SHS | $10.4M | 1,759,295 | — | G9TY5A101 |
| ONKURE THERAPEUTICS INC | COM CL A | $10.2M | 2,238,684 | — | 68277Q105 |
| MAZE THERAPEUTICS INC | COM | $10.1M | 339,276 | — | 578784100 |
| XENON PHARMACEUTICALS INC | COM | $10.1M | 166,550 | — | 98420N105 |
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | $9.4M | 277,848 | — | 881624209 |
| UROGEN PHARMA LTD | COM | $9.3M | 252,395 | — | M96088105 |
| FAETH THERAPEUTICS INC | COM NEW | $9M | 361,010 | — | 81728A207 |
| AMYLYX PHARMACEUTICALS INC | COM | $8.9M | 494,378 | — | 03237H101 |
| DBV TECHNOLOGIES S A | SPONSORED ADS | $8.7M | 528,295 | — | 23306J309 |
| SAVARA INC | COM | $8.6M | 1,403,409 | — | 805111101 |
| VAXCYTE INC | COM | $8.5M | 146,034 | — | 92243G108 |
| CG ONCOLOGY INC | COM | $8.4M | 118,664 | — | 156944100 |
| MINERALYS THERAPEUTICS INC | COM | $8.1M | 298,886 | — | 603170101 |
| ASCENDIS PHARMA A/S | ORD SHS | $7.6M | 28,604 | — | K08588103 |
| AMANAT ACQUISITION CORP | CL A ORD | $7.6M | 750,000 | — | G0375M101 |
| NURIX THERAPEUTICS INC | COM | $7.6M | 313,236 | — | 67080M103 |
| BIOHAVEN LTD | COM | $7.5M | 501,687 | — | G1110E107 |
| PRIME MEDICINE INC | COM | $7.4M | 1,997,552 | — | 74168J101 |
| PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | $7.3M | 674,695 | — | G70077105 |
| OPUS GENETICS INC | COM | $7.3M | 1,783,781 | — | 67577R102 |
| LEXEO THERAPEUTICS INC | COM | $7.3M | 1,565,950 | — | 52886X107 |
| DAMORA THERAPEUTICS INC | COM NEW | $7.3M | 280,000 | — | 36322Q206 |
| REPLIMUNE GROUP INC | COM | $7.3M | 655,784 | — | 76029N106 |
| LEONABIO INC | COM | $7.1M | 777,100 | — | 04746L203 |
| KORRO BIO INC | COM | $7.1M | 540,054 | — | 500946108 |
| RESEARCH ALLIANCE CORP III | ORD SHS CL A | $7M | 650,000 | — | G75226103 |
| INFLARX NV | COM | $6.7M | 3,000,000 | — | N44821101 |
| RELAY THERAPEUTICS INC | COM | $6.7M | 358,333 | — | 75943R102 |
| JANUX THERAPEUTICS INC | COM | $6.5M | 420,881 | — | 47103J105 |
| PLIANT THERAPEUTICS INC | COM | $6.3M | 5,509,724 | — | 729139105 |
| WHITEHAWK THERAPEUTICS INC | COM | $6.1M | 1,341,394 | — | 00032Q104 |
| KRYSTAL BIOTECH INC | COM | $6.1M | 16,420 | — | 501147102 |
| ARBUTUS BIOPHARMA CORP | COM | $6.1M | 1,268,147 | — | 03879J100 |
| PFIZER INC | COM | $6.1M | 252,400 | — | 717081103 |
| BRIGHTHOUSE FINL INC | COM | $6M | 95,523 | — | 10922N103 |
| ABIVAX SA | SPONSORED ADS | $5.9M | 44,400 | Call | 00370M103 |
| EDGEWISE THERAPEUTICS INC | COM | $5.8M | 143,199 | — | 28036F105 |
| ALECTOR INC | COM | $5.8M | 2,883,583 | — | 014442107 |
| FULCRUM THERAPEUTICS INC | COM | $5.7M | 1,565,029 | — | 359616109 |
| ARROWHEAD PHARMACEUTICALS IN | COM | $5.7M | 69,800 | — | 04280A100 |
| ACUMEN PHARMACEUTICALS INC | COM | $5.6M | 2,111,334 | — | 00509G209 |
| OAKTREE ACQUISITION CORP III | UNIT 10/04/2029 | $5.6M | 516,482 | — | G6717R120 |
| GLOBUS MED INC | CL A | $5.5M | 70,100 | — | 379577208 |
| MONTE ROSA THERAPEUTICS INC | COM | $5.2M | 216,752 | — | 61225M102 |
| DISCIPLINED GROWTH | UNIT 99/99/9999 | $5M | 500,000 | — | G2775W127 |
| BHAV ACQUISITION CORP | UNIT 03/18/2031 | $5M | 495,000 | — | G1R59W127 |
| BRIDGEBIO PHARMA INC | NOTE 1.750% 3/0 | $5M | 30,000 | — | 10806XAJ1 |
| BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 | $4.9M | 45,000 | — | 10806XAD4 |
| DANAHER CORP DEL | COM | $4.9M | 25,932 | — | 235851102 |
| BOUNDLESS BIO INC | COM | $4.9M | 1,968,216 | — | 10170A100 |
| AVALYN PHARMACEUTICALS INC | COM SHS | $4.8M | 146,447 | — | 05348Y105 |
| ARS PHARMACEUTICALS INC | COM | $4.8M | 600,999 | — | 82835W108 |
| ATAIBECKLEY INC | COM SHS | $4.8M | 913,242 | — | 04650F101 |
| PRELUDE THERAPEUTICS INC | COM | $4.8M | 900,900 | — | 74065P101 |
| JATT II ACQUISITION CORP | ORD SHS | $4.7M | 417,724 | — | G50765109 |
| REIN THERAPEUTICS INC | COM NEW | $4.7M | 4,500,000 | — | 00887A204 |
| PEPGEN INC | COM | $4.7M | 2,591,085 | — | 713317105 |
| CONTINEUM THERAPEUTICS INC | CL A | $4.6M | 278,961 | — | 21217B100 |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | $4.1M | 1,210,117 | — | 46489V302 |
| APOGEE THERAPEUTICS INC | COM | $4.1M | 31,000 | — | 03770N101 |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | $4M | 118,623 | — | N62509109 |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | $4M | 421,787 | — | 21833P301 |
| BIOGEN INC | COM | $3.9M | 17,900 | — | 09062X103 |
| XENCOR INC | COM | $3.7M | 232,560 | — | 98401F105 |
| SILENCE THERAPEUTICS PLC | ADS | $3.7M | 338,373 | — | 82686Q101 |
| SPRUCE BIOSCIENCES INC | COM NEW | $3.7M | 67,717 | — | 85209E208 |
| PHARVARIS N V | COM | $3.6M | 105,528 | — | N69605108 |
| ENGENE THERAPEUTICS INC | COM | $3.6M | 2,104,986 | — | 29286X101 |
| PALISADE BIO INC | COM | $3.6M | 1,726,662 | — | 696389402 |
| PROTARA THERAPEUTICS INC | COM STK | $3.6M | 940,512 | — | 74365U107 |
| BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | $3.5M | 20,000 | — | 10806XAB8 |
| SAGIMET BIOSCIENCES INC | COM SER A | $3.4M | 437,500 | — | 786700104 |
| BEONE MEDICINES LTD | SPONSORED ADS | $3.3M | 11,701 | — | 07725L102 |
| INVIVYD INC | COM | $3.3M | 3,807,427 | — | 00534A102 |
| TENAX THERAPEUTICS INC | COM NEW | $3.2M | 220,462 | — | 88032L605 |
| ZENTALIS PHARMACEUTICALS INC | COM | $3.2M | 652,750 | — | 98943L107 |
| RELMADA THERAPEUTICS INC | COM | $3.1M | 451,918 | — | 75955J402 |
| DELCATH SYS INC | COM NEW | $2.8M | 224,385 | — | 24661P807 |
| BIOMARIN PHARMACEUTICAL INC | COM | $2.8M | 49,000 | — | 09061G101 |
| SUMMIT THERAPEUTICS INC | COM | $2.8M | 191,869 | — | 86627T108 |
| KEROS THERAPEUTICS INC | COM | $2.6M | 246,818 | — | 492327101 |
| ELEDON PHARMACEUTICALS INC | COM | $2.6M | 647,812 | — | 28617K101 |
| SANOFI SA | SPONSORED ADR | $2.4M | 57,100 | — | 80105N105 |
| AMERICAN EXCEPTIONALISM ACQU | ORD CL A | $2.4M | 205,408 | — | G0273J101 |
| TANGO THERAPEUTICS INC | COM | $2.4M | 76,761 | — | 87583X109 |
| INTUITIVE SURGICAL INC | COM NEW | $2.4M | 6,030 | — | 46120E602 |
| INOVIO PHARMACEUTICALS INC | COM SHS | $2.4M | 2,143,910 | — | 45773H409 |
| OMNIAB INC | COM | $2.3M | 947,412 | — | 68218J103 |
| CAPRICOR THERAPEUTICS INC | COM NEW | $2.2M | 90,593 | — | 14070B309 |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | $2.1M | 30,300 | — | 10919W405 |
| ORUKA THERAPEUTICS INC | COM | $2M | 20,840 | — | 687604108 |
| VYNE THERAPEUTICS INC | COM | $1.9M | 2,950,000 | — | 92941V308 |
| MCKESSON CORP | COM | $1.9M | 2,500 | — | 58155Q103 |
| LEXICON PHARMACEUTICALS INC | COM NEW | $1.8M | 750,000 | — | 528872302 |
| CORVUS PHARMACEUTICALS INC | COM | $1.7M | 117,101 | — | 221015100 |
| CUE BIOPHARMA INC | COM | $1.7M | 55,193 | — | 22978P205 |
| SATELLOS BIOSCIENCE INC | COM | $1.7M | 222,555 | — | 80401L803 |
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | $1.7M | 26,913 | — | G52694109 |
| CONNECT BIOPHARMA HLDGS LTD | SHS | $1.7M | 700,000 | — | G23549101 |
| COHEN CIRCLE ACQUISIT CORP I | UNIT 07/01/2030 | $1.6M | 150,000 | — | G2254C105 |
| ROCKET PHARMACEUTICALS INC | COM | $1.5M | 435,500 | — | 77313F106 |
| FIRST TRACKS BIOTHERAPEUTICS | ORD SHS | $1.4M | 71,910 | — | 337185102 |
| EVOMMUNE INC | COM SHS | $1.4M | 104,035 | — | 30054Y107 |
| C4 THERAPEUTICS INC | COM STK | $1.4M | 291,957 | — | 12529R107 |
| BIOCRYST PHARMACEUTICALS INC | COM | $1.3M | 133,000 | — | 09058V103 |
| SUPERNUS PHARMACEUTICALS | COM | $1.3M | 27,842 | — | 868459108 |
| NOVO-NORDISK A S | ADR | $1.3M | 27,000 | — | 670100205 |
| AVANTOR INC | COM | $1.3M | 130,000 | — | 05352A100 |
| INMED PHARMACEUTICALS INC | COM NEW | $1.2M | 800,000 | — | 457637700 |
| PROMIS NEUROSCIENCES INC | COM SHS | $1.2M | 92,850 | — | 74346M505 |
| ARROWHEAD PHARMACEUTICALS IN | NOTE 1/1 | $1.2M | 10,000 | — | 04280AAC4 |
| ARTIVA BIOTHERAPEUTICS INC | COM | $1.2M | 118,624 | — | 04317A107 |
| TENAYA THERAPEUTICS INC | COM | $1.1M | 1,555,500 | — | 87990A106 |
| ALX ONCOLOGY HLDGS INC | COM | $1.1M | 533,660 | — | 00166B105 |
| ALEXANDRIA REAL ESTATE EQ IN | COM | $1M | 19,500 | — | 015271109 |
| CARTESIAN THERAPEUTICS INC | COM NEW | $1M | 98,877 | — | 816212302 |
| CYCLERION THERAPEUTICS INC | COM | $1M | 298,757 | — | 23255M204 |
| ELECTRONIC ARTS INC | COM | $1M | 4,936 | — | 285512109 |
| TRAVERE THERAPEUTICS INC | NOTE 0.500% 5/1 | $1M | 10,000 | — | 89422GAB3 |
| BIONTECH SE | SPONSORED ADS | $986.3K | 10,600 | — | 09075V102 |
| ACADIA PHARMACEUTICALS INC | COM | $985.6K | 38,955 | — | 004225108 |
| DYNE THERAPEUTICS INC | COM | $951.1K | 42,821 | — | 26818M108 |
| MAPLIGHT THERAPEUTICS INC | COM | $949.7K | 26,497 | — | 56565P103 |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | $939.2K | 17,500 | — | 86366E106 |
| KEEN VISION ACQUISITION CORP | SHS | $930K | 75,000 | Call | G52443119 |
| WAVE LIFE SCIENCES LTD | SHS | $929.6K | 160,000 | — | Y95308105 |
| AURA BIOSCIENCES INC | COM | $924.1K | 130,152 | — | 05153U107 |
| CHURCHILL CAP CORP XI | CL A ORD SHS | $872.5K | 50,000 | — | G2131A108 |
| KAZIA THERAPEUTICS LTD | SPONSORED ADS | $866.6K | 61,550 | — | 48669G303 |
| NUVALENT INC | COM | $857.3K | 6,942 | — | 670703107 |
| LARIMAR THERAPEUTICS INC | COM | $831.9K | 272,745 | — | 517125100 |
| VERA THERAPEUTICS INC | CL A | $786.2K | 18,322 | — | 92337R101 |
| ADAGIO MED HLDGS INC | COM | $785.5K | 1,205,447 | — | 00534B100 |
| ATRIUM THERAPEUTICS INC | COM | $775.9K | 57,688 | — | 04965N104 |
| THERAPEUTICSMD INC | COM NEW | $756.8K | 342,447 | — | 88338N206 |
| IDEAYA BIOSCIENCES INC | COM | $745.4K | 20,000 | — | 45166A102 |
| SI BONE INC | COM | $734.4K | 45,000 | — | 825704109 |
| AMYLYX PHARMACEUTICALS INC | COM | $720.2K | 40,100 | Put | 03237H101 |
| ROYALTY PHARMA PLC | SHS CLASS A | $700.9K | 12,500 | — | G7709Q104 |
| EVOLUS INC | COM | $694K | 100,000 | — | 30052C107 |
| ULTRAGENYX PHARMACEUTICAL IN | COM | $667.8K | 20,000 | Call | 90400D108 |
| IBIO INC | COM NEW | $657.2K | 375,531 | — | 451033708 |
| FORWARD AIR CORP | COM | $651.7K | 48,241 | — | 34986A104 |
| GERON CORP | COM | $647.4K | 505,817 | — | 374163103 |
| STRYKER CORPORATION | COM | $629.7K | 2,000 | — | 863667101 |
| NOVO-NORDISK A S | ADR | $623.2K | 13,000 | Call | 670100205 |
| IOVANCE BIOTHERAPEUTICS INC | COM | $607.7K | 146,090 | — | 462260100 |
| MACROGENICS INC | COM | $599.8K | 129,822 | — | 556099109 |
| GILEAD SCIENCES INC | COM | $587.2K | 4,648 | — | 375558103 |
| NATERA INC | COM | $582.8K | 2,147 | — | 632307104 |
Values are shown exactly as filed. Before 2023 managers reported in thousands of dollars and afterwards in whole dollars; the reporting unit is not always determinable from the document, so nothing is converted automatically.
Source: U.S. Securities and Exchange Commission, Form 13F · as of 2026-08-14